MEDICINOVA, INC. Preferred Stock, Par or Stated Value Per Share
MEDICINOVA, INC. (MNOV) had Preferred Stock, Par or Stated Value Per Share of $0.01 per share as of 2016-12-31, per its 10-K filed 2017-02-14.
Discontinued › Balance Sheet › Equity › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockParOrStatedValuePerShare · last filed 2017-02-14
- 2016-12-31: Preferred Stock, Par or Stated Value Per Share $0.01.
- 2016-09-30: Preferred Stock, Par or Stated Value Per Share $0.01.
- 2016-06-30: Preferred Stock, Par or Stated Value Per Share $0.01.
- 2016-03-31: Preferred Stock, Par or Stated Value Per Share $0.01.
| Period end | Preferred Stock, Par or Stated Value Per Share |
|---|---|
| 2016-12-31 | $0.01 10-K · filed 2017-02-14 |
| 2016-09-30 | $0.01 10-Q · filed 2016-10-25 |
| 2016-06-30 | $0.01 10-Q · filed 2016-07-26 |
| 2016-03-31 | $0.01 10-Q · filed 2016-04-27 |
| 2015-12-31 | $0.01 10-K · filed 2017-02-14 |
| 2015-09-30 | $0.01 10-Q · filed 2015-10-29 |
| 2015-06-30 | $0.01 10-Q · filed 2015-07-30 |
| 2015-03-31 | $0.01 10-Q · filed 2015-05-11 |
| 2014-12-31 | $0.01 10-K · filed 2016-02-25 |
| 2014-09-30 | $0.01 10-Q · filed 2014-11-13 |
| 2014-06-30 | $0.01 10-Q · filed 2014-08-13 |
| 2014-03-31 | $0.01 10-Q · filed 2014-05-08 |
| 2013-12-31 | $0.01 10-K · filed 2015-03-12 |
| 2013-09-30 | $0.01 10-Q · filed 2013-11-07 |
| 2013-06-30 | $0.01 10-Q · filed 2013-08-08 |
| 2013-03-31 | $0.01 10-Q · filed 2013-05-08 |
| 2012-12-31 | $0.01 10-K · filed 2014-03-27 |
| 2012-09-30 | $0.01 10-Q · filed 2012-11-08 |
| 2012-06-30 | $0.01 10-Q · filed 2012-08-09 |
| 2012-03-31 | $0.01 10-Q · filed 2012-05-10 |
| 2011-12-31 | $0.01 10-K · filed 2013-03-28 |
| 2011-09-30 | $0.01 10-Q · filed 2011-11-14 |
| 2011-06-30 | $0.01 10-Q · filed 2011-08-15 |
| 2010-12-31 | $0.01 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |